Early-life growth hormone treatment to offspring of undernourished mothers alters metabolic parameters in primary adipocytes in adulthood

References

• Ahima RS. 2006. Obesity epidemic in need of answers. Gastroenterology 131:991
   Google Scholar
• Akyürek N, Aycan Z, Cetinkaya S, Akyurek O, Yilmaz Agladioglu S, Ertan U. 2013. Peroxisome proliferator activated receptor (PPAR)-gamma concentrations in childhood obesity. Scand J Clin Lab Invest 73:355–360
   PubMed Web of Science ®Google Scholar
• Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, et al. 2005. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11:191–198
   PubMed Web of Science ®Google Scholar
• Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM. 1999. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4:585–595
   PubMed Web of Science ®Google Scholar
• Barker DJ. 2007. The origins of the developmental origins theory. J Int Med 261:412–417
   PubMed Web of Science ®Google Scholar
• Belforte FS, Coluccio Leskow F, Poskus E, Penas Steinhardt A. 2013. Toll-like receptor 4 D299G polymorphism in metabolic disorders: A meta-analysis. Mol Biol Rep 40:3015–3020
   Google Scholar
• Bennett CE, Nsengimana J, Bostock JA, Cymbalista C, Futers TS, Knight BL, McCormack LJ, et al. 2010. CCAAT/enhancer binding protein alpha, beta and delta gene variants: Associations with obesity related phenotypes in the Leeds Family Study. Diabetes Vasc Dis Res 7:195–203
   PubMedGoogle Scholar
• Cai H, Cai J, Tao G. 2013. Association of toll-like receptor 4 polymorphisms with type 2 diabetes mellitus. Acta Pathol Microbiol Immunol Scand 121:605–611
   Google Scholar
• Carroll PV, Drake WM, Maher KT, Metcalfe K, Shaw NJ, Dunger DB, Cheetham TD, et al. 2004. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth. J Clin Endocrinol Metab 89:3890–3895
   Google Scholar
• Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME. 2008. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 16:1248–1255
   PubMed Web of Science ®Google Scholar
• Fusaru AM, Stanciulescu CE, Surlin V, Taisescu C, Bold A, Pop OT, Banita IM, et al. 2012. Role of innate immune receptors TLR2 and TLR4 as mediators of the inflammatory reaction in human visceral adipose tissue. Rom J Morphol Embryol 53:693–701
   Google Scholar
• Gluckman PD, Hanson MA, Cooper C, Thornburg KL. 2008. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359:61–73
   PubMed Web of Science ®Google Scholar
• Gray C, Li M, Reynolds CM, Vickers MH. 2013. Preweaning growth hormone treatment reverses hypertension and endothelial dysfunction in adult male offspring of mothers undernourished during pregnancy. PLoS One 8:e53505
   Google Scholar
• Hanson M, Gluckman P. 2011. Developmental origins of noncommunicable disease: Population and public health implications. Am J Clin Nutr 94:1754S–1758S
   PubMed Web of Science ®Google Scholar
• Jones JR, Barrick C, Kim KA, Lindner J, Blondeau B, Fujimoto Y, Shiota M, et al. 2005. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci USA 102:6207–6212
   PubMed Web of Science ®Google Scholar
• Kawai M, Namba N, Mushiake S, Etani Y, Nishimura R, Makishima M, Ozono K. 2007. Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPARgamma pathway. J Mol Endocrinol 38:19–34
   Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408
   PubMed Web of Science ®Google Scholar
• McMillen IC, Robinson JS. 2005. Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming. Physiol Rev 85:571–633
   PubMed Web of Science ®Google Scholar
• Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis RK, et al. 2007. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 3:e64
   PubMed Web of Science ®Google Scholar
• Moller N, Jorgensen JO. 2009. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30:152–177
   PubMed Web of Science ®Google Scholar
• Nam SY, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB. 2001. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Int J Obes Relat Metab Disord J Int Assoc Study Obes 25:1101–1107
   PubMed Web of Science ®Google Scholar
• Nam SY, Lobie PE. 2000. The mechanism of effect of growth hormone on preadipocyte and adipocyte function. Obes Rev 1:73–86
   PubMedGoogle Scholar
• Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, et al. 2007. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447:1116–1120
   PubMed Web of Science ®Google Scholar
• Ouchi N, Parker JL, Lugus JJ, Walsh K. 2011. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85–97
   PubMed Web of Science ®Google Scholar
• Reynolds CM, Li M, Gray C, Vickers MH. 2013a. Preweaning growth hormone treatment ameliorates adipose tissue insulin resistance and inflammation in adult male offspring following maternal undernutrition. Endocrinology 154:2676–2686
   Google Scholar
• Reynolds CM, Li M, Gray C, Vickers MH. 2013b. Preweaning growth hormone treatment ameliorates bone marrow macrophage inflammation in adult male rat offspring following maternal undernutrition. PLoS One 8:e68262
   PubMed Web of Science ®Google Scholar
• Reynolds CM, McGillicuddy FC, Harford KA, Finucane OM, Mills KH, Roche HM. 2012. Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells – implications for diet-induced insulin resistance. Mol Nutr Food Res 56:1212–1222
   Google Scholar
• Schottl T, Klingenspor M. 2013. Boosting mitochondrial biogenesis in white adipocytes: A route towards improved insulin sensitivity? Mol Metab 2:128–129
   Google Scholar
• Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015–3025
   PubMed Web of Science ®Google Scholar
• Tan NS, Shaw NS, Vinckenbosch N, Liu P, Yasmin R, Desvergne B, Wahli W, Noy N. 2002. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 22:5114–5127
   PubMed Web of Science ®Google Scholar
• Vickers MH. 2011. Developmental programming of the metabolic syndrome – Critical windows for intervention. World J Diabetes 2:137–148
   Google Scholar
• Vickers MH, Ikenasio BA, Breier BH. 2002. Adult growth hormone treatment reduces hypertension and obesity induced by an adverse prenatal environment. J Endocrinol 175:615–623
   Google Scholar
• Xiao H, Lu M, Lin TY, Chen Z, Chen G, Wang WC, Marin T, et al. 2013. Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. Circulation 128:632–642
   Google Scholar
• Yuen KC, Chong LE, Riddle MC. 2013. Influence of glucocorticoids and growth hormone on insulin sensitivity in humans. Diabet Med J Brit Diabet Assoc 30:651–663
   PubMed Web of Science ®Google Scholar